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Background:  Valvular heart surgery (VHS) utilizing cardiopulmonary bypass (CPB) is inevitably associated with 
ischemic-reperfusion injury, which is known to depend on oxygen tension during reperfusion.  The aim of this 
study was to evaluate the effect of arterial oxygen tension during reperfusion on myocardial recovery in patients 
undergoing VHS.
Methods:  Fifty-six patients undergoing isolated VHS were randomly exposed to an oxygen fraction of 0.7 (hyperoxic 
group, n = 28) or 0.5 (normoxic group, n = 28) during reperfusion.  All patients received an oxygen fraction of 
0.7 during CPB.  In the normoxic group, the oxygen fraction was lowered to 0.5 from the last warm cardioplegia 
administration to 1 minute after aortic unclamping, and was then raised back to 0.7.  Hemodynamic data were 
measured after induction of anesthesia, weaning from CPB, and sternum closure.  The frequency of cardiotonic 
medications used during and after weaning from CPB, and the short-term outcomes during the hospital stay were 
also assessed.
Results: The frequency of vasopressin and milrinone use during weaning from CPB, but not norepinephrine, was 
significantly less in the normoxic group.  The post-operative cardiac enzyme levels and short-term outcomes were 
not different between the groups.
Conclusions: Normoxic reperfusion from the last cardioplegia administration to 1 minute after aortic unclamping 
in patients undergoing VHS resulted in significantly less frequent use of vasopressin and inotropics during weaning 
from CPB than hyperoxic reperfusion, although it did not affect the post-operative myocardial enzyme release or 
short-term prognosis.  (Korean J Anesthesiol 2010; 58: 122-128)
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Introduction
    During surgery utilizing cardiopulmonary bypass (CPB), 
the heart is damaged not only by ischemic injury during 
aortic cross clamping (ACC), but also reperfusion injury after 
discontinuation of ACC. Especially, valvular heart surgery 
(VHS) requires a longer CPB duration than coronary artery 
bypass graft (CABG) surgery and has the possibility of reducing 
myocardial function by increased afterload post-operatively 
[1]. Thus, reducing reperfusion injury is very important in 
improving prognosis. 
    The overproduction of reactive oxygen-derived free radicals 
during reperfusion after ischemic injury is a major cause of 
the ischemic-reperfusion myocardial injury [2]. The rate of 
production of reactive oxygen-derived free radicals depends 
on the oxygen tension at reperfusion [3,4]. Previous studies 
have demonstrated that reducing the oxygen concentration 
in the CPB circuit to normoxic levels reduces the production 
of creatine kinase (CK)-MB in patients undergoing CABG 
[5]. However, monitoring devices enabling the continuous 
evaluation of arterial oxygen tension are not available in South 
Korea, and lowering oxygen tension during CPB without an 
appropriate real-time monitoring device for hypoxemia is 
unsafe. Therefore, it is difficult to maintain lower oxygen tension 
throughout CPB. In contrast, by lowering the oxygen fraction to 
0.5 from the last warm cardioplegia administration to 1 minute 
after aortic unclamping, one can access hypoxic events through 
serial arterial blood analysis during the reperfusion period. 
This period is usually short, and the risk of hypoxia is low. By 
lowering the oxygen fraction of the reperfusate, the reactive 
oxygen-derived free radicals, which are the main cause of 
reperfusion myocardial injury that occurs with reoxygenation, 
can be reduced thus facilitatingmyocardial recovery during 
weaning from CPB and after surgery. 
    The aim of this study was to evaluate the effect of arterial 
oxygen tension during reperfusion on myocardial recovery 
in patients undergoing VHS by an analysis of hemodynamic 
variables, frequency of cardiotonic drug use, and short-term 
outcomes.
Materials and Methods
    The study group was comprised of 56 consecutive patients 
undergoing valve replacement surgery due to valvular heart 
disease. The age range was from 18-75 years. The study was 
approved by the institutional review board and all patients 
gave informed consent before inclusion in the study. The pre-
operative evaluation included the past medical history, cardiac 
echogram, common blood cell count, and routine chemistries. 
The exclusion criteria included a left ventricular ejection 
fraction <30%, emergency surgery, anemia, evidence of a 
coagulopathy, chronic lung disease, liver and kidney disease, 
a history of heart surgery, and taking medications, such as 
heparin, coumadin, aspirin, and anti-platelet medications, 
within 5 days. Patients who restarted CPB after failure of the 
first valve replacement surgery, used mechanical support during 
weaning of CPB, and had an oxygen partial pressure < 75 mmHg 
with an inspired oxygen fraction of 0.4 after induction were also 
excluded.
    Patients were randomly allocated to 2 groups based on the 
FiO2 at the time of last reperfusion after aortic unclamping 
during CPB, as follows: group FiO2 0.7 (hyperoxic group, n = 
28); and group FiO2 0.5 (normoxic reperfusion, n = 28). Only 
the perfusionist who controlled the FiO2 during CPB was aware 
of the patient group. The anesthetists and surgeons obtained 
information about the patient groups after surgery.
    Lowering the oxygen fraction to 0.7 during CPB was determined 
by previous surgical experience in our hospital involving safe 
and lower oxygen fraction without continuous monitoring of 
the CPB circuit. In the current study, the oxygen partial pressure 
of arterial blood was 250-350 mmHg in the hyperoxic group. 
The oxygen fraction of 0.7 was the minimal oxygen fraction to 
maintain an oxygen partial pressure >200 mmHg. We obtained 
oxygen partial pressures between 300 and 350 mmHg in the 
hyperoxic group, which were lower than a previous study [5]. 
And the oxygen fraction of 0.5 in the normoxic group was 
determined from preliminary studies that obtained oxygen 
partial pressure 150 mmHg in the normoxic group [5].
    All patients continued cardiac medications, except diuretics, 
and received an intramuscular injection of morphine (0.05 mg/
kg) for pre-medication 1 hour before arrival to the operating 
room. Upon arrival in the operating room, standard monitoring 
devices were applied and a radial artery catheter was inserted 
under local anaesthesia for continuous blood pressure 
monitoring. Pulmonary artery catheter (Swan-Ganz CCOmboⓇ
CCO/SvO2, Edwards Lifesciences LLC, USA) was inserted 
via the right internal jugular vein under local anesthesia for 
continuous measurement of the cardiac index (CI), mixed 
venous oxygen saturation (SvO2), right ventricular ejection 
fraction (RVEF), and right ventricular end-diastolic volume 
index (RVEDVI). Cerebral oxymetry sensors (INVOS 5100TM, 
Somanetics, Troy, MI, USA) were applied to the forehead of the 
patients for continuous monitoring of regional cerebral oxygen 
saturation (rSO2).
    Anesthesia was induced with midazolam (2.5 mg), sufentanil 
(1.5-3.0 μg/kg), and rocuronium bromide (50 mg). After 
tracheal intubation, the lungs were ventilated with a tidal 
volume of 8-10 ml/kg at a rate of 8-12 breaths/min, a FiO2 of 
0.4, and a peak expiratory positive pressure (PEEP) of 5 mmH2O. 
Anesthesia was maintained with a continuous infusion of 
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sufentanil (0.5-1.5 μg/kg/h), vecuronium (1-2 μg/kg/min), 
and sevoflurane (1-2%).
    Heparin was given at a dose of 3 mg/kg before CPB and 
additional heparin was administered to maintain the ACT > 
480 s during CPB. Tranexamic acid (2 g) was loaded before 
CPB; 1 g was mixed to a pump priming solution and infused 
continuously (6 mg/kg/h) until the end of surgery. All the 
patients began CPB with moderate systemic hypothermia, and 
used blood cardioplegia. The bypass circuit had a membrane-
type oxygenator, and the blood flow rate was 2.2-2.4 L/min/m2. 
Acid-base balance was corrected with α-stat. Norepinephrine or 
sodium nitroprusside was infused to maintain the mean arterial 
blood pressure between 60 and 80 mmHg, and vasopressin (1 
unit) was administered when using norepinephrine >0.5 μg/kg/
min. Packed red blood cells were transfused when the Hct was 
<20% during CPB. Sufentanil (1.5 μg/kg) and midazolam (0.05 
mg/kg) were administered before the re-warming period.
    All patients received an oxygen fraction of 0.7 during CPB. 
In the normoxic group, the oxygen fraction was lowered 
to 0.5 from the last warm cardioplegia administration to 1 
minute after aortic unclamping, and then raised back to 0.7. 
In both the hyperoxic and normoxic groups, arterial blood gas 
analysis from an arterial cannula was done and the rSO2 was 
recorded after the last warm cardioplegia administration. Blood 
cardioplegia was a mixture of crystalloid cardioplegia and the 
patienttalloid cin a 4 : 1 ratio. With an oxygen fraction of 0.7, the 
PaO2 of blood cardioplegia was 272 ± 72 blood cardithe PaO2 
of arterial blood was 293 ± 93 arter (P = 0.57). With an oxygen 
fraction of 0.5, the PaO2 of blood cardioplegia and arterial blood 
was 97 ± 48 mmHg and 83 ± 444 mmHg, respectively (P = 0.687). 
There were no specific differences between the PaO2 of blood 
cardioplegia and arterial blood. Because the partial pressure of 
oxygen of crystalloid cardioplegia was about 160-180 mmHg, 
it had no specific effect on the oxygen partial pressure of the 
mixture of cardioplegia and the patientod cardioplegia and 
arterial blood. Because the parti2 of the arterial blood from the 
arterial cannula because there were no differences in the PaO2 
between the blood cardioplegia and arterial blood, and blood 
cardioplegia was administered in a brief period.
    Heparin was reversed with protamine (0.5 mg per 100 units of 
the initial heparin dose) after CPB. An autotransfusion system 
(Cell SaverⓇ 5 system; Haemonetics, MA, USA) was used and the 
remaining blood in the CPB pump was reinfused to the patient 
after processing by the Cell SaverⓇ 5 system. Norepinephrine 
was infused when the mean systemic arterial pressure (MAP) 
was decreased to <60 mmHg during and after weaning of CPB 
and vasopressin was infused continuously (2-4 unit/h) to the 
patients using norepinephrine over 0.3 μg/kg/min who took a 
renin-angiotensin system inhibitor before surgery. Nicardipine 
was infused when the mean systemic arterial pressure (MAP) 
was increased to >90 mm Hg. Milrinone was infused (0.5 μg/
kg/min) after a 50 μg administration to patients who had a CI 
< 2.0 L/min/m2, PCWP >18 mmHg, and LVEF <40% at trans-
esophageal echocardiogram.
    All patients were transferred to the ICU after surgery. Packed 
red blood cells were transfused when the Hct was <25%. Fresh 
frozen plasma was transfused to correct microvascular bleeding 
(bleeding >200 ml/h for 2 consecutive hours) or in the presence 
of abnormal coagulation values (PT[INR] > 1.5). The platelet 
concentrate was transfused when the platelet count was < 
50,000 mm3. 
    Hemodynamic variables, including heart rate (HR), mean 
arterial pressure (MAP), central venous pressure (CVP), mean 
pulmonary artery pressure (MPAP), and CO were recorded 
during induction of anesthesia, weaning from CPB, and 
sternum closure. The amount and frequency of cardiotonic 
medications used during CPB and weaning from CPB was 
recorded. The hemodynamic variables were recorded 6 and 24 
hours after surgery in the the ICU, and cardiac enzymes were 
measured 12 and 24 hours after surgery. The complications 
during admission were recorded. The respiratory support 
period and length of the stay in the ICU and general ward was 
also recorded.
    The sample size calculation was performed based on the 
data of patients undergoing VHS in our hospital. The standard 
deviation (SD) of cardiac output was 0.7, assuming 1 SD 
has clinical significance between groups. This generated an 
estimate of 22 patients in each group with a 90% power to detect 
1 SD in cardiac output (0.7 L/min/m2) and an alpha level of 
0.05. Considering a 20% estimated dropout, we included 28 
patients in each group. Statistical analyses were performed 
using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). Data were 
assessed for normal distribution of variance with a Shapiro-
Wilk test and Q-Q plot. All data are expressed as the number 
of patients or mean ± SD. Discrete variables between the 
groups were compared using Chi-square test, Fisher's exact 
test, and continuous variables were compared using Mann-
Whitney U test. Continuous variables between the groups, 
such as hemodynamic data were compared using repeated-
measures ANOVA. Changes at time points between the groups 
were compared using a Bonferroni correction after the t-test. 
Comparing contra data (data after anesthesia induction) within 
the groups was done using Dunnett’s test. A P value < 0.05 was 
considered statistically significant. 
Results
    There were no significant differences in the demographic 
data, pre-operative medications, and types of surgery between 
the two groups (Table 1).
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    The CPB and ACC times were similar between the two groups. 
The results of arterial blood gas analysis after the last warm 
cardioplegia administration was not significantly different, 
except for the low oxygen partial pressure in the normoxic 
group. The rSO2 result after the last warm cardioplegia 
administration was similar in both groups. The arterial oxygen 
partial pressure after an oxygen fraction of 0.4 in the normoxic 
group for 8 patients between 80 and 100 mmHg, 15 patients 
between 100 and 200 mmHg, and 5 patients >200 mmHg. From 
the last warm cardioplegia administration to the 1 min after 
ACC off was 21.2 ± 7.9 min. 
    The frequency of using norepinephrine during weaning from 
CPB was not different. The dose of using norepinephrine from 
re-warming to weaning from CPB was 0.10 off was between the 
groups were compar and 0.14 of using nog/min in the normoxic 
goup; there were no differences between the groups (P = 0.337). 
But, the number of patients using vasopressin and milrinone 
was significantly less in the normoxic group. Other variables 
related the weaning from CPB were unremarkable (Table 2).
    The changes in hemodynamic variables before and after 
surgery were not significantly different, except that the mean 
arterial pressure 1 hr after weaning of CPB and after sternum 
closure in the normoxic reperfusion group were significantly 
lower in the normoxic goup (Table 3). 
    There were no significant differences in the cardiac enzyme 
levels after surgery, the period of mechanical ventilator support, 
the frequency of cardiotonic medications, and the length of stay 
in the ICU and hospital (Table 4).
Discussion
    This study was designed to evaluate the effect of arterial 
oxygen tension during reperfusion on myocardial recovery and 
hemodynamic improvement and short-term outcome in patients 
undergoing VHS. As a result, we know that the frequency of using Table 1. Pre and Intra-operative Characteristics of Patients
Hr group
 (n = 28)
Nr group
 (n = 28)
P value
Age (yr) 53.6 ± 10.0 55.8 ± 11.0 0.443
Gender (M/F) 17/ 11 14/14 0.420
Height (cm) 161.8 ± 6.9 161.9 ± 8.9 0.592
Weight (kg) 59.3 ± 9.1  61.9 ± 10.5 0.321
BSA (m2) 1.61 ± 0.13  1.68 ± 0.16 0.084
LVEF (%) 63 ± 10  58 ± 13 0.156
Combined disease
    Diabetes mellitus   1   2 1.000
    Hypertension   3   8 0.093
    Chronic renal failure   2   1 0.553
    Liver disease   1   2 0.553
    Atrial fibrillation 14 17 0.420
Medication characteristics
    Calcium channel blockers   2   5 0.225
    Beta-blockers   3   8 0.093
    ARA   6   7 0.752
    ACE-I   7   6 0.752
    Diuretics 16 17 0.786
    Digoxin   8 14 0.101
Procedure
    AVR 7 11 0.252
    MVR 12 8 0.265
    DVR 9 9 1.000
Values are the mean ± SD or number of patients. Hr group:  hyper-
oxic reperfusion group, Nr group:  normoxic reperfusion group, BSA: 
body surface area, LVEF:  left ventricular ejection fraction, ARA:  an-
giotension receptor antagonists, ACE-I:  angiotensin-converting en-
zyme inhibitors, AVR:  aortic valve replacement, MVR:  mitral valve 
replacement, DVR:  double valve replacement.
Table 2. Intra-operative Data
Hr group




CPB duration (min) 139 ± 56 142 ± 51   0.799
ACC duration (min) 99 ± 36 112 ± 43   0.253
rSO2 (%) after last warm cardio-
plegia administration
    Left 57 ± 9 53 ± 7 0.112
    Right  54 ± 10 53 ± 8 0.680
ABGA after last warm 
  cardioplegia administration
    pH 7.43 ± 0.06 7.43 ± 0.07   0.837
    PaCO2 36 ± 7 37 ± 7   0.823
    PaO2 331 ± 43 153 ± 77 < 0.001
    BE -0.4 ± 2.7 0.3 ± 2.3   0.394
Defibrillation after ACC 
  unclamping
11 10   0.865
Medication during CPB weaning
    Norepinephrine 19 23   0.217
    Milrinone   8     2*   0.036
    Vasopressin 11     4*   0.035
Medication after CPB 
    Norepinephrine   5   8   0.342
    Milrinone   8   5   0.342
    Vasopressin   4   2   0.669
Values are the mean ± SD or number of patients. Hr group:  hyper-
oxic reperfusion group, Nr group: normoxic reperfusion group, CPB: 
cardiopulmonary bypass, ACC: aortic cross clamp, rSO2:  regional 
cerebral oxygen saturation, ABGA:  arterial blood gas analysis, BE: 
base excess. *P < 0.05 compared to hyperoxic reperfusion group.
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cardiotropic drugs was decreased in the normoxic reperfusion 
group, but there were no specific effects in the hemodynamics 
and short-term outcomes and cardiac enzymes.
    VHS has the possibility of reducing myocardial function by 
increasing afterload post-operatively, unlike the CABG surgery 
that improve myocardial function by increased coronary flow 
[1]. Also, for the reduction of myocardial injury associated with 
CPB, off-pump coronary artery bypass surgery (OPCAB) can 
replace CABG in high-risk patients for CPB complications [7]. 
But, VHS without CPB has not been generalized. Therefore, it is 
clinically important to find a method that reduces myocardial 
injury from ischemic-reperfusion for patients undergoing VHS.
    The pathophysiology of ischemic-reperfusion injury has 
been evaluated, and there have been two main mechanisms 
proposed: calcium overload and formation of oxygen free 
radicals [2,8]. The injury related overproduction of oxygen 
free radicals was induced by a kind of redox reaction when 
the myocardium was exposed to oxygen, it produced oxygen 
free radicals by a heavy metal-catalyzed reaction. In the first 
5 min after reperfusion, oxygen derived-superoxide anion 
(O2-), hydroxyl radical (•OH, the most important mediator 
in myocardial stunning), and peroxynitrite (ONOO-) were 
generated. They play an important role in reperfusion injuries 
[9-11]. Reperfusion activates polymorphonuclear neutrophils 
(PMNs), and as a result there is an over-production of oxygen 
free radicals by PMNs [10]. At this time, oxygen free radicals 
react to phospholipids, proteins (contraction proteins and 
enzymes), and thiols (SH), and make various cellular damages. 
They injure the sarcolemma by forming lipid and hydrogen 
peroxide, and weaken the membrane bound enzyme-system 
[11]. 
    The production of these free radicals is proportionate to 
oxygen tension (PO2) during reperfusion [3,4]. Methods that 
have been studied to reduce ischemic-reperfusion injury 
include lowering blood pressure during reperfusion [12] and 
reducing blood flow during reperfusion [13], but one of the most 
vigorously researched methods is controlling arterial oxygen 
tension in order to reduce reperfusion injury [14,15]. In relation 
to these studies, one study reported that maintaining normal 
arterial oxygen tension (150 mmHg) during CPB in children 
with cyanotic congenital heart disease resulted in dramatically 
reduced levels of conjugated diens, which represents the lipid 
peroxidation levels of the heart, compared with patients that 
maintained high arterial oxygen tension [16]. A following study 
Table 3. Changes in Hemodynamic Parameter
Parameters Group T1 T2 T3 T4 T5
HR
(beats/min)
Hr 69 ± 16 84 ± 13 83 ± 10 85 ± 16 79 ± 7
Nr 68 ± 10 85 ± 17 82 ± 14 87 ± 12 83 ± 10
mSBP
(mmHg)
Hr 77 ± 10 79 ± 9 79 ± 9 81 ± 12 78 ± 11
Nr 74 ± 11   67 ± 10* 67 ± 9* 75 ± 13 77 ± 12
CVP
(mmHg)
Hr 10 ± 4 10 ± 2 10 ± 3 8 ± 3 8 ± 4
Nr 8 ± 3 9 ± 3 10 ± 2 9 ± 2 8 ± 2
mPAP
(mmHg)
Hr 27 ± 10 22 ± 5 22 ± 5 20 ± 5 19 ± 4
Nr 23 ± 7 21 ± 4 21 ± 3 20 ± 4 19 ± 5
CI
(l/min/m2)
Hr 3.1 ± 0.7 3.1 ± 0.7 3.2 ± 0.9 3.2 ± 0.8 3.4 ± 1.0
Nr 2.9 ± 0.7 3.2 ± 0.9 3.1 ± 0.8 2.7 ± 0.6 3.0 ± 1.0
Values are the mean ± SD. Hr group:  hyperoxic reperfusion group, Nr group: normoxic reperfusion group, T1: post-induction, T2:  1h after 
aortic cross clamp (ACC) unclamping, T3:  after sternum close, T4:  6 h after operation, T5:  24 h after operation, HR:  heart rate, mSBP: mean 
systemic blood pressure, CVP: central venous pressure, mPAP:  mean pulmonary arterial pressure, CI:  cardiac index. *P < 0.05 compared to 
hyperoxic reperfusion group.
Table 4. Post-operative Outcomes
Hr




Ventilator care duration (hr) 13.4 ± 6.3 16.2 ± 7.9 0.149
Length of ICU stay (day) 3.1 ± 1.4 2.9 ± 0.8 0.409
Length of post-operative 
  hospital stay (day)
11.5 ± 5.0 11.2 ± 3.1 0.780
CK-MB
    POD 1 51.9 ± 40.4 73.8 ± 92.8 0.266
    POD 2 41.0 ± 36.7 49.5 ± 40.6 0.456
Pacing in ICU 12 7 0.158
Medication in ICU 
    Norepinephrine 11 11 1.000
    Milrinone 12 12 1.000
    Vasopressin 4 3 0.686
Values are the mean ± SD or number of patients. Hr group:  hyperox-
ic reperfusion group, Nr group: normoxic reperfusion group, ICU: in-
tensive care unit, CK-MB:  creatine kinase-MB, POD:  post-operative 
day.
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reported reduced levels of CK-MB, a biomarker indicating the 
extent of myocardial damage, in adult patients in which arterial 
oxygen tension was maintained in the normal range tension 
during CPB and reperfusion [17]. There is also a study reporting 
that maintaining arterial oxygen tension between 200 and 
250 mmHg during CPB resulted in better recovery of cardiac 
function and effective improvement of aortic and coronary 
blood flow when compared with arterial oxygen tension of 400 
and 450 mmHg [15].
    This study was designed to evaluate the effect of arterial 
oxygen tension during reperfusion on myocardial recovery 
in high-risk patients undergoing VHS. Previous studies 
maintained normal arterial oxygen tension from the start of 
CPB and directly monitored the arterial oxygen saturation or 
oxygen tension during CPB [5,14]. Unfortunately, monitoring 
devices enabling continuous evaluation of arterial oxygen 
tension are not available in South Korea, and lowering oxygen 
tension during CPB without an appropriate monitoring device 
is unsafe. Also, depending on the patient’s condition, the risk 
of hypoxia can increase during rewarming periods due to 
increased oxygen consumption. In fact, we observed oxygen 
tension falling to <100 mmHg in 28% of patients when lowering 
the FiO2 to 0.5.
    The decision was thus made to observe whether controlling 
oxygen tension during the final reperfusion period (period of 
administrating warmed cardioplegia and blood and removing 
the ACC) can reduce myocardial injury due to ischemic-
reperfusion. This period is usually as short as 5-10 minutes, 
and the risk of hypoxia is low due to the high flow rate of the 
CPB machine. 
    The patient group that maintained a normal arterial oxygen 
tension of 150 mmHg by reducing the FiO2 to 0.5 required 
a significantly lower dose of vasopressin and milrinone. 
Otherwise, hemodynamic variables and post-operative cardiac 
biomarkers and short-term prognosis was not different between 
the two groups. Drugs administered to maintain hemodynamic 
variables, which were primary end points, within the normal 
range are thought to be the reason for this lack of discrepancy.
    Also, considering the fact that severe declines in systemic 
vascular resistance after CPB are closely related to disturbances 
in calcium homeostasis and oxidative stress due to ischemic-
reperfusion injury [18]; lower rates of vasopressin or milrinone 
administration in the normoxic group means that incidences 
of severe hypotension or low cardiac output were lower in this 
group. Therefore, it can be said that controlling oxygen tension 
during reperfusion is effective in cardioprotection. 
    The mean arterial pressures were higher in the hyperoxic 
group 1 hour post-CPB and sternum closure. This is thought 
to represent rebound hypertension occurring in more patients 
in the hyperoxic group when vascular tension recovers from 
the dilated state that occurred while weaning from CPB. The 
mean arterial pressure was maintained around 70 mmHg in 
the normoxic group, and there was no difference in the amount 
of peripheral vasoconstrictor administration between the 
two groups. Interestingly, the number of patients requiring 
nicardipine due to high mean arterial pressures > 80 mmHg 
was higher in the hyperoxic group (T2: 6 to 1, P = 0.04; T3: 11 
to 1, P < 0.001). In previous studies, biomarkers of ischemic-
reperfusion injury, such as CK-MB, was significantly lower in 
groups that maintained oxygen tension at 150 mmHg compared 
with hyperoxic groups [5]. In contrast, the present study showed 
no difference in biomarkers or short-term prognosis between 
the two groups. The reason for this discrepancy seems to be 
related to the fact that we were not able to maintain normal 
arterial oxygen tension throughout CPB and therefore all 
patients were reperfused with high oxygen tension cardioplegia 
at all times. Moreover, diverse responses between patients to 
the change in oxygen fraction seems to be a significant factor 
when considering that 11 patients in the normoxic group 
showed oxygen tensions >150 mmHg right before removal of 
ACC despite lowering the oxygen tension to normal levels. Also, 
compared to oxygen tensions of >400 mmHg in the hyperoxic 
groups of previous studies [5,15], the hyperoxic group of the 
present study showed oxygen tensions between 250 and 350 
mmHg, leading to smaller differences between the groups.
    Because oxygen tensions were controlled with the beginning 
of administration of warmed cardioplegia, measuring the 
oxygen tension of cardioplegia was needed in order to measure 
the oxygen tension of the initial reperfusion fluid. There was 
no difference in oxygen tension between the cardioplegia and 
arterial blood, and the arterial blood was administered through 
the aortic cannula, thus this does not seem to have affected the 
accuracy of this study.
    In addition, patients undergoing VHS were enrolled in this 
study which may lead to various degrees of myocardial injury, 
depending on the type of surgery, whereas previous studies 
were conducted in patients undergoing CABG. It increased the 
SD of cardiac enzymes after surgery, and the number of patients 
in this study was insufficient; however, the primary end point 
in this study was a difference of hemodynamic variables, not 
cardiac enzymes. 
    Therefore, although there were no significant improvements 
in levels of cardiac biomarkers or short-term prognosis, the 
reduced amount of administered peripheral vasoconstrictors 
and inotropes after only a short period of oxygen tension 
modulation seems to be of clinical importance. Vasoconstrictors 
and inotropes administered during CPB means hemodynamic 
instability after reperfusion, and influences the prognosis and 
complications of the patient post-operatively [19,20].
    As a result, we lowered the oxygen fraction of 0.7 to 0.5 from 
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the administration of last cardioplegia to 1 min after ACC to 
reduce reperfusion injury during VHS, there were no specific 
effects at the hemodynamics and short-term outcome and 
cardiac enzymes, but the frequency using cardiotropic drugs 
was decreased in the normoxic reperfusion group. Reduced 
oxygen tension during reperfusion after aortic unclamping 
on CPB is thought that convenient and safe supportive 
management technique to reduce reperfusion injury. 
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